{"title": "Responding to global vaccine demand, Cytiva pledges $52.5M to build South Korean factory", "author": "Joseph Keenan", "url": "https://www.fiercepharma.com/manufacturing/cytiva-commits-52-5-million-to-build-manufacturing-plant-south-korea", "hostname": "fiercepharma.com", "description": "Cytiva, a Massachusetts-based research and biopharma manufacturing specialist, will shell out $52.5 million to build a plant in South Korea to make disposable cell-culture | Cytiva, a Massachusetts-based research and biopharma manufacturing specialist, will shell out $52.5 million to build a plant in South Korea to make disposable cell-culture bags used in vaccine production.", "sitename": "FiercePharma", "date": "2021-09-24", "cleaned_text": "Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Resources Podcasts Fierce Events Industry Events Webinars Whitepapers Survey Events Subscribe Subscribe Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Resources Podcasts Fierce Events Industry Events Webinars Whitepapers Survey Events Subscribe Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us "}